AMRUTANJAN HEALTH CARE
Back to Balance Sheet
|
AMRUTANJAN HEALTH CARE Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹5.29 Cr | ₹4.06 Cr | ₹3.63 Cr | ₹3.18 Cr | ₹2.46 Cr |
What is the latest Total Non-Current Liabilities ratio of AMRUTANJAN HEALTH CARE ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹5.29 Cr |
Mar2023 | ₹4.06 Cr |
Mar2022 | ₹3.63 Cr |
Mar2021 | ₹3.18 Cr |
Mar2020 | ₹2.46 Cr |
How is Total Non-Current Liabilities of AMRUTANJAN HEALTH CARE Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹5.29 Cr | 30.51 | |
Mar2023 | ₹4.06 Cr | 11.74 | |
Mar2022 | ₹3.63 Cr | 14.19 | |
Mar2021 | ₹3.18 Cr | 29.34 | |
Mar2020 | ₹2.46 Cr | - |
Compare Total Non-Current Liabilities of peers of AMRUTANJAN HEALTH CARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMRUTANJAN HEALTH CARE | ₹2,011.4 Cr | 1.7% | -7.5% | 16.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,557.0 Cr | 2.3% | -0.8% | 32.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,994.0 Cr | 3.2% | 1.1% | 51.5% | Stock Analytics | |
CIPLA | ₹116,494.0 Cr | 0.3% | -2% | 10% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,297.0 Cr | -1.8% | 2.7% | 12.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,035.0 Cr | 2% | 1.5% | 38% | Stock Analytics |
AMRUTANJAN HEALTH CARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMRUTANJAN HEALTH CARE | 1.7% |
-7.5% |
16.3% |
SENSEX | -1% |
-5% |
5.6% |
You may also like the below Video Courses